Cathartic agent nephropathy based on sodium phosphate in kidney patients transplanted. Report of case
PDF (Español)
PDF

Keywords

Chronic kidney disease
nephropathy by sodium phosphate
Diagnosis.(MeSHsource).

How to Cite

1.
Pineda R, Molano A, Flórez A, D`Achiardi R, Wancjer B. Cathartic agent nephropathy based on sodium phosphate in kidney patients transplanted. Report of case. Rev. Colomb. Nefrol. [Internet]. 2016 Jul. 11 [cited 2024 Mar. 18];3(1):52-7. Available from: https://revistanefrologia.org/index.php/rcn/article/view/240

Abstract

Sodium phosphate nephropathy consists of damage to the kidneys caused by the use of laxatives containing sodium phosphate.  Depending on the time of use of these drugs used for colonic preparation this disease can be acute or chronic. The acute condition can be cured with a suitable treatment, but the chronic condition can cause irreversible kidney damage.This case is about a patient who receives our services in the unit in Fundación Cardio Infantil in Bogotá, Colombia, with an acute kidney injurywith renal transplant being monitored. Sodium phosphate was used to be prepared the kidney for a colonoscopy.
https://doi.org/10.22265/acnef.3.1.240
PDF (Español)
PDF

References

1. Vanner SJ, MacDonald PH, Paterson WG, Prentice RS, Da Costa LR, Beck IT. A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution [Golytely] in the preparation of patients for colonoscopy. Am J Gastroenterol. 1990 Abr;85(4):422–7.

2. Heher EC, Thier SO, Rennke H, Humphreys BD. Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation. Clin J Am Soc Nephrol. 2008 Sep;3(5):1494–503. doi: 10.2215/CJN.02040408. Epub 2008 Jul 2.

3. Weiss J, Thorp ML. Acute phosphate nephropathy: a cause of chronic kidney disease. BMJ Case Reports. 2011. doi:10.1136/bcr.04.2010.2876.

4. Cho SG, Yi JH, Han SW, Kim HJ. Electrolyte Imbalances and Nephrocalcinosis in Acute Phosphate Poisoning on Chronic Type 1 Renal Tubular Acidosis due to Sjögren’s Syndrome. J Korean Med Sci. 2013 Feb;28(2):336–9. doi: 10.3346/jkms.2013.28.2.336.

5. Seol DC, Hong SN, Kim JH, Sung IK, Park HS, Lee JH, et al. Change in renal function after sodium phosphate preparation for screening colonoscopy. World J Gastroenterol. 2010 April 28;16(16):2010–6. doi: 10.3748/wjg.v16.i16.2010.

6. Ehrenpreis ED, Parakkal D, Semer R, Du H. Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration. Colorectal Dis. 2011 Sep;13(9):e270–5. doi: 10.1111/j.1463-1318.2011.02679.x.

7. Sica DA, Carl D, Zfass AM. Acute phosphate nephropathy–an emerging issue. Am J Gastroenterol. 2007 Sep;102(9):1844–7.

8. Gumurdulu Y, Serin E, Ozer B, Gokcel A, Boyacioglu S. Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation. J Gastroenterol Hepatol. 2004 Ene;19(1):68–72.

9. Abaskharoun R, Depew W, Vanner S. Changes in renal function following administration of oral sodium phosphate or polyethylene glycol for colon cleansing before colonoscopy. Can J Gastroenterol. 2007 Abr;21(4):227–31.

10. Brunelli SM, Lewis JD, Gupta M, Latif SM, Weiner MG, Feldman HI. Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol. 2007 Dic;18(12):3199–205.

11. Russmann S, Lamerato L, Marfatia A, Motsko SP, Pezzullo JC, Olds G, et al. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol. 2007
Dic;102(12):2655–63.

12. Lieberman DA, Ghormley J, Flora K. Effect of oral sodium phosphate colon preparation on serum electrolytes in patients with normal serum creatinine. Gastrointest Endosc. 1996 May;43(5):467–9.

13. Gonlusen G, Akgun H, Ertan A, Olivero J, Truong LD. Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. Arch Pathol Lab Med. 2006 Ene;130(1):101–6.

14. Desmeules S, Bergeron MJ, Isenring P. Acute phosphate nephropathy and renal failure. N Engl J Med. 2003 Sep 4;349(10):1006–7.

15. Beloosesky Y, Grinblat J, Weiss A, Grosman B, Gafter U, Chagnac A. Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Intern Med. 2003 Abr 14;163(7):803–8.

16. Markowitz GS, Perazella MA. Acute phosphate nephropathy. Kidney Int. 2009 Nov;76(10):1027–34.

17. Adamcewicz M, Bearelly D, Porat G, Friedenberg FK. Mechanism of Action and Toxicities of Purgatives Used for Colonoscopy Preparation. Expert Opin Drug Metab Toxicol. 2011 Ene;7(1):89–101.

18. Joo WC, Lee SW, Yang DH, Han JY, Kim MJ. A case of biopsy-proven chronic kidney disease on progression from acute phosphate nephropa¬thy. Kidney Res Clin Pract. 2012 Jun;31(2):124–7.

19. Chevarría J, de Arriba G. Nephroprevention in acute phosphate nephropathy. Kidney Int. 2010;77:646. doi:10.1038/ki.2009.533.
No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.

Dimensions


PlumX


Downloads

Download data is not yet available.